Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.
about
Mevalonate kinase deficiency: current perspectivesInnovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis PathwayMolecular mechanisms regulating NLRP3 inflammasome activationMevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible LinkRecent Advances of the NLRP3 Inflammasome in Central Nervous System DisordersInitiation and perpetuation of NLRP3 inflammasome activation and assemblyImmunologic manifestations of autophagyHyper-IgD syndrome/mevalonate kinase deficiency: what is new?Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's diseaseHepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in MiceKeeping the immune system in check: a role for mitophagy.Increased expression of IL-18 in the serum and islets of type 1 diabetics.NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activationEffect of lycopene against gastroesophageal reflux disease in experimental animalsImpaired mitochondrial degradation by autophagy in the skeletal muscle of the aged female interleukin 10 null mouse.Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects.Monogenic autoinflammatory diseases.Regulation of innate immunity by the molecular machinery of macroautophagy.Role of inflammasomes in intestinal inflammation and Crohn's disease.Perception of self: distinguishing autoimmunity from autoinflammation.Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond.Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2.Autoinflammatory Syndromes in Children.Inflammasome activation by nucleic acids and nucleosomes in sterile inflammation… or is it sterile?Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency.Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds.Mitochondrial DNA in innate immune responses and inflammatory pathology.The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy.Autophagy Proteins ATG5 and ATG7 Are Essential for the Maintenance of Human CD34(+) Hematopoietic Stem-Progenitor Cells.Clinical update on inflammasomopathies.TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.Dysregulated IL-1β Secretion in Autoinflammatory Diseases: A Matter of Stress?Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease.Activation of autophagy by FOXO3 regulates redox homeostasis during osteogenic differentiation.Knockdown of MVK does not lead to changes in NALP3 expression or activation.The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases.Autophagy dysfunction in autoinflammatory diseases.
P2860
Q26738667-3880595E-1C10-41AD-84F6-54F3F3BD72EBQ26771260-AA9A167D-819A-47EC-888F-DFCAC82927D6Q26778556-2CD0C525-3669-441E-88D0-A2637F2860E7Q26799973-E7799052-CD23-4D37-9A25-0D0D1CEED787Q28076650-A6AD9EF0-99EB-4690-A966-5E3F512C16B9Q28082177-C5B576AA-732A-47AF-948F-2AF3433B8B11Q28256530-F8B70A93-E143-4212-B0F7-6125A3B4A3EEQ28262203-AF39F627-31E1-4521-B2AD-AD96C4D33980Q28393932-6E935FE7-79E3-4D8A-8BF7-DD5168EB55FCQ28553822-035867A3-EF29-4EDB-A9FD-02D37A437713Q34042190-E8EF82E3-17B5-46CE-AB1D-1A184947F752Q35044541-2D9BA48E-2510-41F9-9BB0-08811E760B2DQ35208558-FC226770-90E9-4115-B028-6FDFF28E3CC2Q35601757-28BE187F-F207-4B0A-860A-83C8649ED4A7Q35608480-91189B50-2273-4EE5-82BB-437A1887FD0BQ35848853-72F40682-C964-41C0-B5FA-3FF51396A8BFQ36335877-611B8F2A-42A9-40D6-BC05-8E77E264DCBAQ38211947-365A6258-EC66-4BA0-9B56-4F504E87A6E3Q38253147-8926E337-0ADB-4466-97AE-74A4CA7777E2Q38291767-DF0E4412-FB85-4B78-91CC-E1E16321562EQ38474054-FA2C53B3-8786-4B31-B33C-6F3598BFFB5DQ38494648-C2F3DB55-F0E9-4197-BA86-CF62B7A14475Q38701191-AF87E947-C7C9-4DA7-BF00-FFD5DE47D8D1Q38715104-0458DCF8-6433-4297-8094-5E11B61E39BEQ38735363-0EBECC45-F450-4F12-AA07-32FF1ACE5BF4Q38871606-718F54C1-37C8-4D1B-B383-7254DED72218Q38967639-93C7158D-B931-401E-844E-6CE733BB85A0Q39001725-F5AAAA68-9DDF-495C-8F73-0C8B15068744Q39231387-4F3CE91F-57C0-48E3-9930-5C5A6941E425Q39278658-A8046909-687E-4F96-A44F-C3652BBA3F71Q39956926-87A1D9C6-483B-4589-ADD8-F5E3E9D27F54Q40062051-CAA30538-9E2E-4D28-8075-AE2407D2BA41Q40193922-69B48C4B-1D79-40F4-AE02-6E8E73347E9EQ40246150-81C5772F-D34B-4ADE-8944-E80F070E8945Q40625676-AFFC2656-AB1E-4060-92C3-B26EB58592CBQ41539053-84271FBB-CABD-4E26-BF3F-F6194F5C42E3Q41575635-B920BBCE-7BD8-4FE1-AF1A-D7BECE81E40AQ41844039-66401E3E-DF41-4B11-8C89-70D92EC18429Q47104734-124EB267-E472-4D35-B68B-CECC0A2E05F9Q47434993-701E3483-9D12-456F-9A59-D1245A34A4EC
P2860
Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Defects in mitochondrial clear ...... interleukin-1β hypersecretion.
@en
Defects in mitochondrial clear ...... interleukin-1β hypersecretion.
@nl
type
label
Defects in mitochondrial clear ...... interleukin-1β hypersecretion.
@en
Defects in mitochondrial clear ...... interleukin-1β hypersecretion.
@nl
prefLabel
Defects in mitochondrial clear ...... interleukin-1β hypersecretion.
@en
Defects in mitochondrial clear ...... interleukin-1β hypersecretion.
@nl
P2093
P2860
P50
P356
P1476
Defects in mitochondrial clear ...... interleukin-1β hypersecretion
@en
P2093
Joost Frenkel
Kalliopi Pervolaraki
Lieneke H Jongeneel
Lotte Nijhuis
Marielle van Gijn
Paul J Coffer
Pier G Mastroberardino
Robert van der Burgh
P2860
P304
P356
10.1074/JBC.M113.536920
P407
P577
2013-12-19T00:00:00Z